Company Analysis

Assembly Biosciences, Inc. (ASMB)

Nasdaq: ASMB · Pharmaceutical Preparations · South San Francisco, CA · filing with the SEC since 2008
Grade5.4
◀ Past 4.7● Present 6.1▶ Future 5.0
4 est.

Who runs Assembly Biosciences, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Okazaki Jason A
CEO and President. First filing Mar 2020, latest Nov 3, 2026, 15 filings in all.
Officers reporting now
6
of 11 people with a filing in the last fifteen months
Directors reporting now
5
30 people on the record since 2010
Officerssales are open-market, Nov 3, 2025 to Nov 3, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Okazaki Jason ACEO and PresidentMar 2020Nov 3, 20262 · $100,000
Delaney William E IVChief Scientific OfficerMay 2020Nov 3, 2026none
Gaggar AnujChief Medical OfficerNov 2023Nov 3, 20262 · $100,000
White Nicole SChief Manufacturing OfficerSep 2023Nov 3, 20264 · $100,000
Bjorkquist Jeanette MPFO and PAOSep 2022Nov 3, 20265 · $0.00
Mchutchison John GChief Executive OfficerAug 2019Jun 5, 2026none
Directorssales are open-market, Nov 3, 2025 to Nov 3, 2026
NameRoleFirst filingLatest filingSales, 12 months
Altig Anthony EdirectorJan 2012Jun 5, 2026none
Consylman GinadirectorOct 2020Jun 5, 2026none
Houghton MichaeldirectorJul 2021Jun 5, 2026none
Johnson-Pratt LisadirectorMay 2021Jun 5, 2026none
Mahony SusandirectorDec 2017Jun 5, 2026none
Owners of more than 10% of a classsales are open-market, Nov 3, 2025 to Nov 3, 2026
NameRoleFirst filingLatest filingSales, 12 months
Gilead Sciences, Inc.10% ownerOct 2023May 27, 2026none
Earlier names on the record21, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ASMB · research, not advice